OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial
Lisa Paschold, Alexander Stein, Benjamin Thiele, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006678-e006678
Open Access | Times Cited: 4
Lisa Paschold, Alexander Stein, Benjamin Thiele, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006678-e006678
Open Access | Times Cited: 4
Showing 4 citing articles:
Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises
Sara Bandini, Paola Ulivi, Tania Rossi
Cells (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 6
Sara Bandini, Paola Ulivi, Tania Rossi
Cells (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 6
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)
Joseph Tintelnot, Alexander Stein, Salah‐Eddin Al‐Batran, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Joseph Tintelnot, Alexander Stein, Salah‐Eddin Al‐Batran, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer
Peipei Xie, Xiaoli Zhang, Tianyi Liu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Peipei Xie, Xiaoli Zhang, Tianyi Liu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Inflammatory signature and restriction of adaptive immunity are associated with unfavorable outcomes on immune checkpoint blockade in patients with advanced head and neck squamous cell carcinoma
Lisa Paschold, Christoph Schultheiß, Paul Schmidt-Barbo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Lisa Paschold, Christoph Schultheiß, Paul Schmidt-Barbo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
